About Rose Pharma
Rose Pharma is a clinical phase biopharmaceutical company focusing on development of novel treatments
for irritable bowel syndrome (IBS) and functional dyspepsia (FD), disorders which affect 10-20% of the
general population and which are large unmet clinical needs.
The platform technology is based around glucagon-like peptide-1 (GLP-1).
|
|
| 2008 - 01-11
|
|
Gastrotech(Rose Pharma) signs licensing agreement with Eli Lilly and Company for compound to
treat Irritable Bowel Syndrome |
|
Read more
|
|
|
